| Group . | Age at diagnosis, mean ± SD (y) . | Age at first birth (y) . | RNA (ng)* . | aaRNA (ng) . | Ratio 260/280 . |
|---|---|---|---|---|---|
| Parous Control | 63.23 ± 8.77† | 24.70 ± 4.88 | 59.79 ± 53.51‡,§ | 1,460.48 ± 1,454.13§ | 2.01 ± 0.01 |
| Parous case | 69.35 ± 9.21†,∥ | 24.97 ± 4.06 | 365.35 ± 525.62‡ | 1,596.34 ± 1,502.99 | 2.02 ± 0.03 |
| Nulliparous control | 56.71 ± 5.60∥ | NA | 148.52 ± 192.97 | 1,256.51 ± 630.21 | 2.06 ± 0.14 |
| Nulliparous case | 66.00 ± 12.43 | NA | 268.10 ± 307.61§ | 887.41 ± 387.16 | 2.01 ± 0.03 |
| Group . | Age at diagnosis, mean ± SD (y) . | Age at first birth (y) . | RNA (ng)* . | aaRNA (ng) . | Ratio 260/280 . |
|---|---|---|---|---|---|
| Parous Control | 63.23 ± 8.77† | 24.70 ± 4.88 | 59.79 ± 53.51‡,§ | 1,460.48 ± 1,454.13§ | 2.01 ± 0.01 |
| Parous case | 69.35 ± 9.21†,∥ | 24.97 ± 4.06 | 365.35 ± 525.62‡ | 1,596.34 ± 1,502.99 | 2.02 ± 0.03 |
| Nulliparous control | 56.71 ± 5.60∥ | NA | 148.52 ± 192.97 | 1,256.51 ± 630.21 | 2.06 ± 0.14 |
| Nulliparous case | 66.00 ± 12.43 | NA | 268.10 ± 307.61§ | 887.41 ± 387.16 | 2.01 ± 0.03 |
Total amount of RNA in nanograms obtained by laser capture microdissection from each sample.
Parous controls vs parous cases, t = 2.31, P < 0.02.
Parous controls vs parous cases, t = 2.37, P < 0.02.
Parous control vs nulliparous case, t = 2.76, P = 0.01.
Parous case vs nulliparous control, t = 3.94, P < 0.001.